A California jury has ordered Novartis to pay $178 million to rival drugmaker Daiichi Sankyo for willfully infringing two cancer drug patents.
The Delhi High Court has cleared the way for a slew of generic diabetes drugs to arrive on the Indian market after it rejected AstraZeneca’s request for a blocking order.
The US Patent Trial and Appeal Board has given the go-ahead for an inter partes review of a Chinese pharma company’s US patent related to a treatment for Alzheimer’s.
A Cannabis industry event company has filed a counterclaim suit to invalidate trademarks held by a competitor, who has accused them of unfair competition.
The Patent Trial and Appeal Board has ruled that a Medytox patent for its wrinkle treatment should not have been granted.
A Nevada federal court judge has overruled objections to a previous ruling on a dispute between investors and cannabidiol company CV Sciences.
Barnes & Thornburg has added three new life science IP lawyers to the firm’s new Boston office.
The UK’s Competition and Markets Authority has imposed fines of £260 million on drug companies for raising the price of life-saving hydrocortisone tablets by 10,000%.
Novartis should pay a Daiichi Sankyo subsidiary, Plexxikon, $47 million in overdue IP royalties, according to an argument presented before a federal court in California this week.
Actor and comedian Sacha Baron Cohen is suing a US medical cannabis company for its use of his controversial Borat character on a billboard advertisement without his authorisation.